跳至主要内容
临床试验/CTRI/2024/01/061413
CTRI/2024/01/061413尚未招募Unknown

Evaluation of the safety and the efficacy of a novel polyherbal mouthwash containing Emblica officinalis,Cinnamomum cassia,Silicate of magnesia,Nigella sativa and Eucalyptus globulus oil in patients with gingivitis:A randomized controlled trial - NI

DR ZADC AMU ALIGARH0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • APPARENTLY HEALTHY INDIVIDUALS WITH
  • PRESENCE OF ATLEAST 20 NATURAL TEETH
  • DIAGNOSIS OF GINGIVITIS-DENTAL BIOFILM INDUCED

排除标准

  • 1)PREGNANCY AND LACTATION
  • 2)DECOMPENSATED SYSTEMIC DISEASE
  • 3)DEGENERATIVE BONE DISEASE
  • 4)SJOGREN SYNDROME
  • 5)ADVANCED PERIODONTAL OR ORTHODONTIC DISEASE
  • 6)HISTORY OF ORAL PROPHYLAXIS WITHIN 6 MONTHS
  • 7)HISTORY OF TAKING ANTIBIOTICS,ANTICOAGULANT,IMMUNOSUPPRESSIVE,ANTI-INFLAMMATORY MEDICATION OR USING ANTI-BACTERIAL
  • MOUTH RINSES FOR PAST 6 MONTHS.
  • 8)SMOKING,DRUG AND ALCOHOL ABUSE

研究者

发起方
DR ZADC AMU ALIGARH

相似试验

已完成
不适用
Evaluation of the safety and effectiveness of the MID-C/ApiFix system in adolescent idiopathic scoliosis.Spinal curvature1002837710005944
NL-OMON43676Vrije Universiteit Medisch Centrum33
已完成
不适用
Prospective evaluation of efficacy and safety of argon plasma coagulation therapy with submucosal injection prior to ablation in Barrett's esophagusC15.5Lower third of oesophagus
DRKS00003369HSK Wiesbaden60
进行中(未招募)
Unknown
Safety and effectiveness clinical evaluation of the range of injectable medical devices HYDRAGEL C in facial aesthetic treatmentSubjects across groups present with moderate to severe facial aesthetic concerns, including peri-oral lines, nasolabial folds, lip volume deficits, and cheeks/cheekbones volume deficit, as gauged by various dermatological scalesSkin and Connective Tissue Diseases
ISRCTN13586698ouna Aesthetics75
进行中(未招募)
不适用
Clinical study to evaluate the safety and effectiveness of the use of two hyaluronic acid injectable products (Perfectha® Derm Lidocaine and Perfectha® Deep Lidocaine) in the treatment of lipsFor Perfectha® Derm Lidocaine: very thin to thin lip volume and with lip contour somewhat well-defined to poorly definedfor Perfectha® Deep Lidocaine: thin to moderate lip volume
ISRCTN72858148Sinclair Pharma68
尚未招募
4 期
euroEPO in mild-moderate Alzheimer's disease amnesic variantmild-moderate Alzheimer's diseaseAlzheimer DiseaseBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesTauopathiesNeurodegenerative DiseasesNeurocognitive DisordersMental DisordersDementia
RPCEC00000410Center of Molecular Immunology (CIM)1,456